Stock Events

Stock Events

Innoviva 

$21.25
57
+$0.29+1.38% Tuesday 20:00
+$0.00+0%Tuesday 20:01After hours

Statistics

Day High
21.26
Day Low
21.25
52W High
25.15
52W Low
16.52
Volume
11,830
Avg. Volume
-
Mkt Cap
1.54B
P/E Ratio
3.55
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Sep 15
$0.25
Jun 15
$0.25
Mar 15
$0.25
Dec 14
$0.25
Sep 14
$0.25
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-1.14
-0.02
1.1
2.22
Expected EPS
0.5125
Actual EPS
N/A

Financials

65.92%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
411.33MRevenue
271.17MNet Income

Analyst Ratings

40.67Average Price Target
The highest estimate is 46.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow INVA. It's not an investment recommendation.
Microsoft
17
MSFT
Alphabet
17
GOOGL
NVIDIA
15
NVDA
Meta Platforms
15
META

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
GSK
GSK
Mkt Cap99.18B
GlaxoSmithKline, partner in respiratory products, also competes in overlapping market segments.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca competes in the respiratory and biopharmaceutical market, similar to Innoviva's interests.
Vertex Pharmaceuticals
VRTX
Mkt Cap128.19B
Vertex Pharmaceuticals is involved in treating cystic fibrosis, a respiratory condition, thus competing with Innoviva.
Biogen
BIIB
Mkt Cap31B
Biogen competes in the biopharmaceutical space with a focus on innovative therapies, overlapping with Innoviva's market.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals competes in the biopharmaceutical field, focusing on innovative drug development like Innoviva.
AMGEN
AMGN
Mkt Cap224.63B
Amgen operates in the biopharmaceutical sector, focusing on innovative treatments, competing with Innoviva.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences competes in the biopharmaceutical market with a focus on innovation and research, similar to Innoviva.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie operates in the biopharmaceutical field, with a focus on research-based pharmaceuticals, competing with Innoviva.
Merck
MRK
Mkt Cap335.14B
Merck & Co. competes in the pharmaceutical and biopharmaceutical sectors, focusing on innovative therapies.
Pfizer
PFE
Mkt Cap152.69B
Pfizer competes across various therapeutic areas, including respiratory diseases, overlapping with Innoviva's market interests.

About

Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.
Show more...
CEO
Pavel Raifeld
Employees
159
Country
United States
ISIN
US45781M1018
WKN
000A2AC9U

Listings

STU
DE
HVE.STU
MU
DE
HVE.MU
BOATS
BOATS
INVA.BOATS
XNAS
US
INVA

0 Comments

Share your thoughts

FAQ

What is Innoviva stock price today?▼
The current price of INVA is $21.25 USD — it has increased by +1.38% in the past 24 hours. Watch Innoviva stock price performance more closely on the chart.
What is Innoviva stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Innoviva stocks are traded under the ticker INVA.
Is Innoviva stock price growing?▼
INVA stock has risen by +2.11% compared to the previous week, the month change is a -2.12% fall, over the last year Innoviva has showed a +3.56% increase.
What is Innoviva market cap?▼
Today Innoviva has the market capitalization of 1.54B
When is the next Innoviva earnings date?▼
Innoviva is going to release the next earnings report on November 11, 2026.
What were Innoviva earnings last quarter?▼
INVA earnings for the last quarter are -1.14 USD per share, whereas the estimation was 0.44 USD resulting in a -361.47% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Innoviva revenue for the last year?▼
Innoviva revenue for the last year amounts to 411.33M USD.
What is Innoviva net income for the last year?▼
INVA net income for the last year is 271.17M USD.
Does Innoviva pay dividends?▼
Yes, INVA dividends are paid quarterly. The last dividend per share was 0.25 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Innoviva have?▼
As of August 19, 2026, the company has 159 employees.
In which sector is Innoviva located?▼
Innoviva operates in the Health & Wellness sector.
When did Innoviva complete a stock split?▼
The last stock split for Innoviva was on June 17, 2013 with a ratio of 1:100.
Where is Innoviva headquartered?▼
Innoviva is headquartered in BURLINGAME, United States.